Search Results

GE HealthCare Plans $945 Million All-Cash Acquisition of Sofie Biosciences: Full-Scale Positioning in the "Final Mile" Delivery of Positron Radiopharmaceuticals and CDMO Capacity

GE HealthCare, the Chicago-based medical imaging and radiodiagnostics giant, has announced that it has entered into a definitive acquisition agreement to acquire radiopharmaceutical company Sofie Biosciences in an all-cash deal valued at $945 million from private equity firm Trilantic North America. The transaction is expected to complete all regulatory approvals and closing procedures by July 2027, and is expected to be accretive to GE HealthCare's revenue growth and adjusted earnings in the first full fiscal year following closing. Founded in 2008 and headquartered in Dulles, Virginia, Sofie Biosciences has built a broad radiopharmaceutical production and distribution network across the United States...

2026-10-08

GE HealthCare Plans $1 Billion Acquisition of Radiopharmaceutical Company Sofie Biosciences

According to reports, healthcare giant GE HealthCare is in talks to acquire radiopharmaceutical company Sofie Biosciences for $1 billion. It is understood that this acquisition will be another major business move for GE HealthCare since its spin-off from General Electric Company in 2023. Previously, the company reached an agreement in March of this year to acquire software company Intelerad for $2.3 billion, aiming to enhance its cloud-based enterprise imaging service capabilities. Sofie Biosciences was founded in 2008 and is headquartered in Dulles, Virginia. The company has a well-established radiopharmaceutical production and distribution network and provides contract manufacturing services. In addition, Sofie Biosci...

2026-09-15

GE HealthCare's StarGuide GX Digital 4D CZT SPECT/CT Receives FDA 510(k) Clearance in the U.S.

GE HealthCare recently announced that its new digital 4D CZT SPECT/CT system, StarGuide GX, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system had previously obtained CE marking, and this U.S. clearance marks progress in the clinical adoption of its next-generation molecular imaging technology. Designed for theragnostics and precision medicine needs, StarGuide GX is a comprehensive SPECT/CT system. It supports imaging at multiple energy levels, enables general-purpose SPECT imaging, and is tailored for emerging tracer applications, including investigational α-emitters, aiming to provide imaging support for clinicians and researchers exploring new pathways in diagnosis, treatment planning, and therapeutic response monitoring.

2026-09-09

GE HealthCare's Photonova Spectra Photon-Counting CT Receives CE Mark, to Be Commercialized in Countries Recognizing CE Marking

On August 31, GE HealthCare announced that its advanced photon-counting computed tomography (PCCT) system, Photonova Spectra, has received CE marking. The system utilizes GE HealthCare's proprietary Deep Silicon™ detector technology. This certification will expand the system's availability in countries and regions that recognize the CE mark and pave the way for its clinical use. According to reports, Photonova Spectra is designed to address the growing patient volumes and increasing diagnostic complexity faced by healthcare institutions today, aiming to provide clinicians with clearer and more timely imaging information. Leveraging deep silicon detector technology, the system can acquire spectral and spatial imaging information in each scan...

2026-09-01

Leo Cancer Care and GE HealthCare Announce Collaboration to Advance Upright Radiotherapy Workflow Integration

Leo Cancer Care recently announced a commercial collaboration with GE HealthCare, focusing on GE HealthCare's advanced imaging solutions and intelligent radiotherapy software, with plans to apply related technologies to Leo Cancer Care's future upright radiotherapy systems to streamline patient and data workflows from simulation to treatment delivery. Under the collaboration framework, the two parties will explore integration pathways between GE HealthCare's intelligent radiotherapy software iRT and Leo Cancer Care's future upright radiotherapy solutions. iRT is an AI-assisted software developed for radiotherapy settings, primarily used to connect information, workflows, and applications across different systems, helping healthcare institutions simplify complex processes, enable patients to enter radiotherapy more promptly, and reduce clinician burden.

2026-08-30